Hoth Therapeutics Risk Adjusted Performance
| HOTH Stock | | | USD 0.69 -0.05 -6.76% |
Risk-Adjusted Performance (RAP) measures the return an equity would have generated if it carried the same total risk (standard deviation) as the market. Derived from the Sharpe Ratio, RAP is expressed in percentage terms, making direct comparison across assets with different volatility profiles straightforward. Below is Hoth Therapeutics's current Risk Adjusted Performance with peer comparisons and related risk metrics.
Current Risk Adjusted Performance Value
Hoth Therapeutics registers a Risk Adjusted Performance of 0.0362, reflecting positive but modest risk-adjusted return. Hoth Therapeutics has produced a positive return relative to risk, though the margin is limited.
RAP | = | (ER[a] - RFR) * STD[b])/STD[b]RFR |
| = | 0.0362 | |
Risk Adjusted Performance Peers Comparison
The peer group averages 0.01 for Risk Adjusted Performance, with Hoth Therapeutics at 0.0362 falling above that level. Readings span -0.1301 (Aspire BioPharma) to 0.1526 (Dare Bioscience). Hoth Therapeutics's risk-adjusted return exceeds the peer average, indicating more efficient compensation for risk taken.
Risk Adjusted Performance Relative To Other Indicators
The chart below plots Risk Adjusted Performance against Maximum Drawdown for Hoth Therapeutics and its peers. Each point represents one equity — position along the horizontal axis shows Risk Adjusted Performance while the vertical axis shows Maximum Drawdown. Equities that cluster in different quadrants carry distinct risk-return profiles. Use the dropdowns to swap in other indicators for either axis.
At
0.04 for Risk Adjusted Performance and
48.52 for Maximum Drawdown, Hoth Therapeutics's cross-indicator ratio sits almost
1,340 . This indicates Maximum Drawdown substantially exceeds Risk Adjusted Performance for Hoth Therapeutics.
Methodology, Assumptions & Data Sources
Hoth Therapeutics' Risk Adjusted Performance currently stands at 0.0362. The Risk Adjusted Performance for Hoth Therapeutics is produced by transforming raw price history into a standardized measure according to the indicator's defined methodology. The underlying data comes from exchange-reported daily closes with corporate action adjustments applied where relevant. The calculation assumes continuous price data across the selected period. All readings are presented as reference data.
Other Technical Indicators